Xyzagen Provides Dignify Therapeutics with Strategic Laboratory Solution
Pittsboro, NC – January 1, 2024
Xyzagen, Inc., a leading pharmacokinetics consultancy and contract research organization (CRO), has established a collaboration with Dignify Therapeutics to provide strategic in vivo vivarium solutions designed to support their therapeutic research and development. This collaboration strengthened Dignify Therapeutics’ capacity to conduct cutting-edge nonclinical research studies and facilitate their therapeutic breakthroughs.
“We are pleased to collaborate with Dignify Therapeutics to provide them with the additional tools and expertise needed to further their mission of advancing healthcare,”
said Christopher Crean, CEO and Founder at Xyzagen. “Our strategic laboratory solutions support their goals and enhanced their operational capabilities.”
“Dignify’s collaboration with Xyzagen has provided the laboratory facilities required for the successful execution of Dignify’s drug discovery programs. In addition, Xyzagen’s leadership and staff have added valuable support for our research.”
Dr. Lesley Marson, Dignify’s Vice President of Preclinical Research and Development added
About Xyzagen
Xyzagen augments a client’s pharmacology and pharmacokinetics drug development team. As a leading pharmacokinetics consultancy and contract research organization with wet lab and rodent vivarium facilities, Xyzagen is able to push model informed drug development into its First-in-Rat® and First-in-Mouse® discovery platforms as well as support late stage clinical noncompartmental PK, PopPK and Quantitative Medicine.
Our knowledge in pharmacology and pharmacokinetics allows the client to expand their core scientific team during the critical period of candidate selection up to the PreIND meeting and through clinical development and the preNDA meeting. Xyzagen’s a boutique organization which allows small clients to work directly and strategically with experts during their drug development programs.
